How to Get Jardiance in Missouri: Telehealth, Prescriptions, and Pharmacy Access

What Is Jardiance and Why Missouri Patients Are Seeking It

Jardiance (empagliflozin) is an FDA-approved sodium-glucose cotransporter-2 (SGLT2) inhibitor manufactured by Boehringer Ingelheim and Eli Lilly. It blocks glucose reabsorption in the proximal renal tubule, lowering blood sugar, blood pressure, and body weight simultaneously [1]. Beyond glycemic control, its cardiovascular and renal benefits have made it one of the most-prescribed medications in its class across the United States.

The landmark EMPA-REG OUTCOME trial (N=7,020, median follow-up 3.1 years) demonstrated that empagliflozin reduced the risk of cardiovascular death by 38% compared with placebo in adults with type 2 diabetes and established cardiovascular disease (hazard ratio 0.62 to 95% CI 0.49 to 0.77, P<0.001) [2]. That single finding reshaped guideline recommendations and drove patient demand sharply upward.

The FDA has granted Jardiance three distinct approvals: type 2 diabetes (2014), heart failure with reduced ejection fraction (2021), and chronic kidney disease (2023) [1]. The American Diabetes Association's 2024 Standards of Care recommend SGLT2 inhibitors as preferred add-on agents in patients with type 2 diabetes who also have heart failure, CKD, or atherosclerotic cardiovascular disease, independent of HbA1c [3]. That broad indication set means Missouri patients with any of these conditions may be candidates.

Missouri has seen a steady rise in SGLT2 inhibitor prescriptions since 2019. The CDC reports that Missouri's age-adjusted prevalence of diagnosed diabetes reached 11.4% as of 2022, above the national average of 10.5%, giving a large local patient population a clinically valid reason to ask about access [4].

Who Can Prescribe Jardiance in Missouri

Any licensed Missouri prescriber with a valid DEA registration and a Missouri state license may prescribe Jardiance. That includes MDs, DOs, nurse practitioners (NPs) with collaborative practice agreements or full practice authority, and physician assistants (PAs) working within their supervising physician's scope.

Missouri granted NPs full practice authority in August 2024 under Senate Bill 90, meaning NPs no longer require a collaborative practice agreement to prescribe Schedule IV and below medications independently. Because empagliflozin is not a controlled substance, any Missouri-licensed NP may prescribe it without a supervising physician's co-signature as of that date.

PAs in Missouri still require a supervising physician agreement, but that agreement can be executed with a physician in any specialty, including internal medicine, endocrinology, cardiology, and nephrology. These specialties are the most common prescribers of Jardiance in the state.

Telehealth providers licensed in Missouri follow the same prescribing rules as in-person providers. Missouri Revised Statutes §191.1145 permits synchronous audio-video visits to establish a new patient-prescriber relationship and generate a valid prescription [5]. A telephone-only (audio-only) visit satisfies the prescribing standard only if the provider can document clinical necessity for the absence of video.

How to Get a Jardiance Prescription in Missouri: Step by Step

Getting a prescription requires four sequential steps: an initial consultation, baseline lab review, provider sign-off, and pharmacy fulfillment.

Step 1: Schedule a clinical visit. Book an appointment with a Missouri-licensed provider, either in person or via a telehealth platform registered to prescribe in Missouri. The visit must include a clinical assessment, medication history review, and discussion of contraindications (eGFR <20 mL/min/1.73 m², end-stage renal disease, active urinary tract infection, or type 1 diabetes).

Step 2: Complete baseline labs. The provider will order or review recent lab results before writing the prescription. Most Missouri clinics accept labs drawn within the prior 90 days. Required panels are detailed in the section below.

Step 3: Receive and verify the prescription. The provider sends an electronic prescription to your chosen pharmacy via Missouri's e-prescribing network. Missouri law (Missouri Revised Statutes §338.095) requires controlled substances to be e-prescribed, but since Jardiance is non-controlled, paper or fax prescriptions remain legal, though e-prescribing is the standard [6].

Step 4: Pharmacy fulfillment or mail order. A retail Missouri pharmacy typically fills the prescription within 24 to 48 hours. Mail-order pharmacies (including those affiliated with major insurers and independent online pharmacies licensed in Missouri) ship within 3 to 7 business days.

Labs Required Before Jardiance Is Prescribed in Missouri

Most Missouri prescribers require four specific laboratory values before initiating empagliflozin. These are not arbitrary; they directly determine whether the drug is safe and at what dose it should be started.

Estimated glomerular filtration rate (eGFR) and serum creatinine. The FDA label specifies that Jardiance is not recommended for glycemic control when eGFR is <30 mL/min/1.73 m² [1]. For the CKD indication, it may be used down to eGFR <20 mL/min/1.73 m² only under specialist supervision. The EMPEROR-Reduced trial (N=3,730) confirmed the cardiovascular benefit down to eGFR of 20 mL/min/1.73 m², but prescribers in Missouri's primary care settings generally do not initiate below eGFR 30 without nephrology input [7].

HbA1c. Establishes baseline glycemic control and documents the T2D indication for insurance purposes. Missouri commercial insurers typically require a recent HbA1c (within 90 days) for prior authorization.

Urine albumin-to-creatinine ratio (UACR). Required when the CKD indication is being used. The CREDENCE trial (N=4,401) showed canagliflozin reduced progression to end-stage kidney disease by 30%, and subsequent EMPA-KIDNEY data (N=6,609) confirmed a 28% reduction in kidney disease progression or cardiovascular death with empagliflozin specifically (P<0.001) [8]. UACR establishes the CKD staging that justifies the prescription.

Basic metabolic panel (BMP). Checks potassium and bicarbonate. Euglycemic diabetic ketoacidosis (DKA) is a rare but serious risk; patients with low bicarbonate at baseline warrant closer monitoring or a delay in initiation.

Most Missouri telehealth providers accept results from LabCorp, Quest Diagnostics, or any CLIA-certified Missouri laboratory. Some platforms can order labs directly through their patient portal before the prescribing visit, shortening the total time-to-prescription.

Telehealth Prescribing of Jardiance in Missouri

Missouri telehealth law explicitly permits a licensed provider to initiate a prescription for a non-controlled substance after a synchronous audio-video visit, without a prior in-person encounter [5]. This means a Missouri resident can complete the entire process, from first consultation to electronic prescription, without leaving home.

Several national telehealth platforms (including HealthRX) operate Missouri-licensed prescribers who see patients via video and can send prescriptions to retail pharmacies or mail-order services within Missouri. The visit typically takes 20 to 40 minutes and covers:

• Chief complaint and medication history
• Review of uploaded lab results
• Cardiovascular and renal risk stratification
• Contraindication screening
• Shared decision-making on dose (10 mg or 25 mg)

The American Association of Clinical Endocrinologists (AACE) 2023 Comprehensive Diabetes Management Algorithm supports SGLT2 inhibitor initiation in any patient with T2D and an eGFR above 30, regardless of HbA1c, if cardiovascular or renal risk is present [9]. Telehealth prescribers in Missouri follow this guidance and document it in the visit note to support prior authorization requests.

One practical point: Missouri Medicaid (MO HealthNet) reimburses synchronous telehealth visits at parity with in-person visits for most covered services as of January 2023. Patients on MO HealthNet should confirm their managed care plan's specific telehealth benefit before scheduling.

Prior Authorization for Jardiance in Missouri

Most Missouri commercial insurers and MO HealthNet require prior authorization (PA) before covering Jardiance. Failing to obtain PA before the first fill is the most common reason Missouri patients experience prescription delays.

A standard Missouri PA submission for Jardiance includes:

• Confirmed diagnosis (ICD-10 codes E11.xx for T2D, I50.xx for heart failure, or N18.xx for CKD)
• Recent HbA1c for T2D indication (insurers commonly require HbA1c at or above 7.0%)
• Documentation of at least one prior diabetes medication trial (usually metformin, unless contraindicated)
• eGFR and UACR values for heart failure and CKD indications
• Prescriber attestation that the patient has established cardiovascular disease, heart failure, or CKD, per the FDA-approved label

The American Heart Association's 2022 heart failure guideline gives SGLT2 inhibitors a Class I recommendation for patients with heart failure with reduced ejection fraction, regardless of diabetes status [10]. Missouri insurers covering the heart failure indication often accept this guideline citation in the PA letter as sufficient clinical justification.

PA approval timelines in Missouri range from 24 hours (urgent review) to 14 business days (standard review). If denied, a prescriber-initiated peer-to-peer review resolves most first-level denials in the cardiovascular and CKD categories, because the guideline support is strong.

Boehringer Ingelheim's Lilly Cares and BI Cares patient assistance programs offer free or reduced-cost Jardiance to eligible Missouri patients who are uninsured or underinsured. Income thresholds and enrollment forms are available directly through the manufacturer. Patients whose annual household income falls at or below 400% of the federal poverty level may qualify for zero-cost medication.

Missouri Pharmacy Access: Retail, Mail Order, and 503A Compounding

Retail pharmacies. All major retail chains operating in Missouri (including CVS, Walgreens, Walmart Pharmacy, and Price Chopper Pharmacy) stock 10 mg and 25 mg Jardiance tablets. GoodRx and similar discount programs reduce the cash price to approximately $520 to $560 per 30-count supply at most Missouri locations, though the manufacturer's savings card brings the out-of-pocket cost to $10 per month for eligible commercially insured patients.

Mail-order pharmacies. Missouri-licensed mail-order pharmacies can fill a 90-day supply, reducing per-unit cost significantly. Express Scripts, CVS Caremark, and OptumRx all ship to Missouri addresses and accept Jardiance prescriptions electronically.

503A compounding pharmacies. Missouri-licensed 503A compounding pharmacies may prepare empagliflozin formulations for individual patients under a valid prescription when a commercially available product is not clinically appropriate (for example, a patient requiring a non-standard dose or a formulation without certain excipients). The FDA's 503A framework [11] requires compounding to be based on a legitimate patient-specific prescription, and the Missouri Board of Pharmacy enforces these requirements through annual inspection cycles. Compounded empagliflozin is not bioequivalent-tested, and prescribers must document the clinical rationale in the medical record.

Transfer of an existing prescription. Missouri pharmacy law permits transfer of a non-controlled prescription between licensed pharmacies one time (some pharmacies allow multiple transfers under specific conditions). To transfer a Jardiance prescription from an out-of-state pharmacy to a Missouri pharmacy, the receiving Missouri pharmacy contacts the dispensing pharmacy directly. Missouri recognizes out-of-state prescriptions for non-controlled substances, so no new prescription from a Missouri provider is legally required solely because of a state-line transfer.

Jardiance Dosing Reference for Missouri Patients

The FDA-approved dosing schedule is straightforward but varies by indication [1]:

Type 2 diabetes: Start at 10 mg once daily in the morning, with or without food. Titrate to 25 mg once daily if additional glycemic control is needed and eGFR remains above 45 mL/min/1.73 m².

Heart failure (HFrEF and HFpEF): 10 mg once daily. The dose is not titrated upward for this indication. The EMPEROR-Preserved trial (N=5,988) showed a 21% relative risk reduction in cardiovascular death or heart failure hospitalization at the 10 mg dose (P<0.001) [12].

Chronic kidney disease: 10 mg once daily, continued even as eGFR declines, down to eGFR of approximately 20 mL/min/1.73 m² under specialist guidance. The EMPA-KIDNEY trial (N=6,609) found benefit down to eGFR as low as 20, with a consistent effect across the range of baseline eGFR values studied [8].

Patients should take Jardiance in the morning to minimize nocturia caused by the osmotic diuresis effect. Food intake does not affect absorption.

Side Effects Missouri Prescribers Discuss Before Initiating

Every Missouri prescriber is expected to counsel patients on the following before writing the first prescription, per FDA label requirements [1]:

• Genital mycotic infections: Occur in approximately 10% of women and 4% of men in clinical trials. Most respond to a single course of antifungal therapy.
• Urinary tract infections: Modestly increased risk, particularly in women with recurrent UTI history. An active UTI is a contraindication to initiating Jardiance.
• Volume depletion and hypotension: Relevant in patients on loop diuretics or those with systolic blood pressure <100 mmHg. Dose reduction of diuretics may be needed.
• Euglycemic DKA: Rare but serious. Risk increases with low carbohydrate intake, surgery, or prolonged fasting. Missouri patients should be instructed to hold Jardiance 3 days before elective surgery.
• Lower limb amputation signal: The FDA label carries a warning based on CANVAS trial data (canagliflozin). EMPA-REG OUTCOME did not show a statistically significant amputation signal for empagliflozin, but Missouri prescribers typically assess peripheral vascular disease before initiating any SGLT2 inhibitor [2].
• Fournier's gangrene: Extremely rare (fewer than 55 cases reported across all SGLT2 inhibitors as of the 2018 FDA safety communication). Patients should report perineal pain or swelling immediately.

How Long Until Jardiance Arrives in Missouri

The total time from scheduling a first visit to receiving the medication depends on the pathway chosen:

• Telehealth visit with e-prescription to retail pharmacy: Same-day prescription delivery if the pharmacy has stock; medication in hand within 24 to 48 hours of the visit.
• Telehealth visit with prior authorization required: Add 1 to 14 business days for PA processing before the pharmacy can fill.
• Mail-order 90-day supply: 3 to 7 business days after the prescription is verified and insurance is confirmed.
• 503A compounded formulation: Typically 5 to 10 business days from prescription receipt by the compounding pharmacy.

Patients in acute heart failure exacerbation who need rapid initiation should see a Missouri cardiologist or hospitalist in person; that clinical setting allows same-day initiation under direct monitoring.

Missouri Medicaid (MO HealthNet) Coverage Details

MO HealthNet's preferred drug list currently includes empagliflozin for the heart failure (I50.xx) and CKD (N18.xx) indications with prior authorization. Coverage for type 2 diabetes as a standalone indication without a comorbid cardiovascular or renal condition is more restricted under the fee-for-service MO HealthNet program as of 2025.

Missouri Medicaid managed care plans (including Home State Health, Missouri Care, and Healthy Blue) maintain their own formularies and may offer broader T2D coverage than fee-for-service MO HealthNet. Patients should call the member services number on their MO HealthNet card to confirm current formulary status before the prescribing visit. PA criteria across all three managed care organizations require documented HbA1c above 7.0% and at least one prior diabetes medication trial.

The Missouri Department of Social Services publishes quarterly preferred drug list updates at dss.mo.gov; the most recent update should be checked at the time of prescribing.